These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27543656)

  • 1. In vitro activity of SecA inhibitors in combination with carbapenems against carbapenem-hydrolysing class D β-lactamase-producing Acinetobacter baumannii.
    Chiu CH; Liu YH; Wang YC; Lee YT; Kuo SC; Chen TL; Lin JC; Wang FD
    J Antimicrob Chemother; 2016 Dec; 71(12):3441-3448. PubMed ID: 27543656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinetobacter baumannii Extracellular OXA-58 Is Primarily and Selectively Released via Outer Membrane Vesicles after Sec-Dependent Periplasmic Translocation.
    Liao YT; Kuo SC; Chiang MH; Lee YT; Sung WC; Chen YH; Chen TL; Fung CP
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7346-54. PubMed ID: 26369971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activities of imipenem combined with BLI-489 against class D β-lactamase-producing Acinetobacter baumannii.
    Wang YC; Huang SW; Chiang MH; Lee IM; Kuo SC; Yang YS; Chiu CH; Su YS; Chen TL; Wang FD; Lee YT
    J Antimicrob Chemother; 2021 Jan; 76(2):451-459. PubMed ID: 33057603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major
    Stewart NK; Toth M; Alqurafi MA; Chai W; Nguyen TQ; Quan P; Lee M; Buynak JD; Smith CA; Vakulenko SB
    mBio; 2022 Jun; 13(3):e0036722. PubMed ID: 35420470
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae.
    Poirel L; Kieffer N; Nordmann P
    J Antimicrob Chemother; 2016 Jan; 71(1):156-61. PubMed ID: 26416781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S; Vickers A; Woodford N; Livermore DM
    J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.
    Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
    Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):890-900. PubMed ID: 22299471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Insights into the Mechanism of Carbapenemase Activity of the OXA-48 β-Lactamase.
    Smith CA; Stewart NK; Toth M; Vakulenko SB
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii.
    Vázquez-Ucha JC; Martínez-Guitián M; Maneiro M; Conde-Pérez K; Álvarez-Fraga L; Torrens G; Oliver A; Buynak JD; Bonomo RA; Bou G; González-Bello C; Poza M; Beceiro A
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
    Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the novel class D β-lactamase OXA-679 involved in carbapenem resistance in Acinetobacter calcoaceticus.
    Tietgen M; Kramer JS; Brunst S; Djahanschiri B; Wohra S; Higgins PG; Weidensdorfer M; Riedel-Christ S; Pos KM; Gonzaga A; Steglich M; Nübel U; Ebersberger I; Proschak E; Göttig S
    J Antimicrob Chemother; 2019 Jun; 74(6):1494-1502. PubMed ID: 30844059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.
    Marti S; Sánchez-Céspedes J; Alba V; Vila J
    Int J Antimicrob Agents; 2009 Feb; 33(2):181-2. PubMed ID: 18977642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U; Chatsuwan T
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
    Amudhan SM; Sekar U; Arunagiri K; Sekar B
    Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.
    Laishram S; Anandan S; Devi BY; Elakkiya M; Priyanka B; Bhuvaneshwari T; Peter JV; Subramani K; Balaji V
    J Chemother; 2016 Aug; 28(4):297-303. PubMed ID: 27461479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
    Alharbe R; Almansour A; Kwon DH
    Int J Med Microbiol; 2017 Oct; 307(7):409-414. PubMed ID: 28781060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii.
    Wang Y; Li X; Wang D; Sun S; Lu C
    Lett Appl Microbiol; 2020 Mar; 70(3):189-195. PubMed ID: 31808159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five novel carbapenem-hydrolysing OXA-type β-lactamase groups are intrinsic in Acinetobacter spp.
    Tian J; Zhang G; Ju Y; Tang N; Li J; Jia R; Feng J
    J Antimicrob Chemother; 2018 Dec; 73(12):3279-3284. PubMed ID: 30247543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.